Related Experiment Video
Updated: Aug 9, 2026

Analysis of Yersinia enterocolitica Effector Translocation into Host Cells Using Beta-lactamase Effector Fusions
Published on: October 13, 2015
Novel pathogenetic mechanism in a clinical isolate of Yersinia enterocolitica KU14
Yoshinori Sato1, Kenichi Kaneko, Takeshi Sasahara
1Environmental Infectious Disease, Graduate School of Medical Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara-shi, Kanagawa 228-8555, Japan.
Abstract:
Yersinia enterocolitica induces a broad range of gastrointestinal syndromes, including acute enteritis. We previously reported that the clinical isolate, Y. enterocolitica KU14, which lacks pYV, was still capable of causing clinical infection. The present study demonstrated that KU14 did not trigger the death of macrophages in vitro, unlike WA-314 (ATCC51871, which harbors the pYV virulence plasmid). However, the intracellular growth of KU14 in the macrophages was greater than that of WA-C (ATCC51872, a non-plasmid harboring the derivative pYV plasmid). Treatment with a cholesterol-binding drug (beta-cyclodextrin) that affected lipid rafts resulted in a dramatic reduction in the intracellular growth of KU14. These data clearly indicate that the enhanced intracellular growth of KU14 is related to lipid raft-mediated infection.
Insights
Yersinia enterocolitica KU14, lacking the pYV plasmid, exhibits enhanced intracellular growth in macrophages. This growth is mediated by lipid rafts, suggesting a novel infection mechanism for this pathogen.
Area of Science:
- Microbiology
- Immunology
- Pathogen-host interactions
Background:
- Yersinia enterocolitica is a significant cause of bacterial gastroenteritis.
- The pYV virulence plasmid is typically associated with Yersinia pathogenicity.
- Previous work showed Y. enterocolitica KU14, lacking pYV, can still cause infection.
Purpose of the Study:
- To investigate the mechanism behind the intracellular survival and growth of Y. enterocolitica KU14 in macrophages.
- To determine the role of lipid rafts in Y. enterocolitica KU14 infection.
Main Methods:
- Macrophage cell culture and infection assays.
- Comparison of Y. enterocolitica strains with and without the pYV plasmid.
- Treatment with beta-cyclodextrin to disrupt lipid rafts.
Main Results:
- Y. enterocolitica KU14 did not induce macrophage death, unlike pYV-harboring strains.
- KU14 demonstrated significantly greater intracellular growth within macrophages compared to a non-plasmid strain.
- Disruption of lipid rafts with beta-cyclodextrin markedly reduced intracellular KU14 growth.
Conclusions:
- The pYV plasmid is not essential for Y. enterocolitica to infect macrophages.
- Enhanced intracellular growth of Y. enterocolitica KU14 is dependent on lipid raft-mediated mechanisms.
- Lipid rafts represent a potential target for therapeutic intervention against Yersinia infections.
Related Concept Videos
Bacterial Gastroenteritis
Plague
Lysogenic Cycle of Bacteriophages
Colonisation of Pathogens
Determinants of Bacterial Pathogenicity and Virulence

